{{Short description|British-Zambian physician}} {{Use British English|date=September 2014}} {{Use dmy dates|date=February 2020}} {{Infobox scientist | honorific_prefix = | name = Sir Alimuddin Zumla | honorific_suffix = {{post-nominals|country=GBR|KBE|size=100%}}, FRCP, FRCPath, FRSB | image = Professor Alimuddin Zumla-1.jpg | image_size = 150px | caption = | birth_date = {{birth date and age|1955|5|15|df=y}} | death_date = | birth_place = Fort Jameson, Northern Rhodesia | fields = Medicine<br />Tuberculosis<br />Global health | workplaces = University College London<br />UCL Hospitals NHS Foundation Trust | alma_mater = University of Zambia<br />London School of Hygiene & Tropical Medicine<br />Royal Postgraduate Medical School<br />University of Texas Health Science Center at Houston | doctoral_advisors = Keith McAdam <br /> David Isenburg | thesis_title = Characterisation of human monoclonal antibodies to phenolic glycolipid -1 from patients with leprosy : and production of their anti-idiotypes | thesis_url = http://193.63.81.241/record=b1533167~S16 | thesis_year = 1987 | academic_advisors = | doctoral_students = | known_for = Tuberculosis research<br />Tropical medicine<br />Infectious diseases<br />Mass-gathering medicine<br/>COVID-19 research | author_abbrev_bot = | author_abbrev_zoo = | awards = 2022: Manson Medal<ref>{{Cite web |title=RSTMH Medals and Awards winners 2022 {{!}} RSTMH |url=https://rstmh.org/news-blog/news/rstmh-medals-and-awards-winners-2022 |access-date=2022-10-22 |website=rstmh.org}}</ref> <br />2021: EU-EDCTP Pascoal Mocumbi Prize<ref name="pasc">{{cite web |title=International research and capacity building award for UCLH consultant {{!}} UCLH Biomedical Research Centre |url=https://www.uclhospitals.brc.nihr.ac.uk/news/international-research-and-capacity-building-award-uclh-consultant |website=www.uclhospitals.brc.nihr.ac.uk |date=20 October 2021 |access-date=30 October 2021}}</ref> <br /> 2020: Mahathir Science Award<ref name="maha">{{cite web |title=2020 MAHATHIR SCIENCE AWARD RECIPIENT IS THOUGHT LEADER IN TB, TB/HIV AND EMERGING AND RE-EMERGING EPIDEMIC INFECTIONS |url=http://msa-foundation.org/blog/2020-mahathir-science-award-recipient/ |website=MSA FOUNDATION |access-date=30 October 2021}}</ref><ref>{{Cite web|last=Halid|first=Oleh Suzalina|date=2020-08-16|title=Prof Alimuddin terima Anugerah Sains Mahathir ke-11|url=https://www.bharian.com.my/berita/pendidikan/2020/08/721935/prof-alimuddin-terima-anugerah-sains-mahathir-ke-11|access-date=2020-08-18|website=BH Online|language=ms}}</ref> <br /> 2018: The Union Medal<ref>{{Cite news|url=https://www.theunion.org/news-centre/news/the-2018-union-awards-recognise-significant-achievement-from-across-the-globe|title=The 2018 Union awards recognise significant achievement from across the globe|work=The Union|access-date=2018-10-30|language=en}}</ref> <br /> 2015: Contribution to World Class Research Award<ref>{{Cite web |date=2015-03-20 |title=Staff honoured at excellence awards ceremony |url=https://www.uclhospitals.brc.nihr.ac.uk/news/staff-honoured-excellence-awards-ceremony-0 |access-date=2023-05-21 |website=UCLH Biomedical Research Centre |language=en}}</ref> <br /> 2014: Donald Mackay Medal<ref>{{Cite web |date=2014-10-07 |title=BRC researcher awarded for work in tropical health |url=https://www.uclhospitals.brc.nihr.ac.uk/news/brc-researcher-awarded-work-tropical-health |access-date=2023-05-21 |website=UCLH Biomedical Research Centre |language=en}}</ref> <br /> 2012: Karolinska Institutet Science Award<ref name="Karolinska">{{cite web |title=Karolinska Institutet Annual Prize Lecture Award 2012 |url=https://www.uclh.nhs.uk/Research/BRC/News/Pages/KarolinskaInstitutetAnnualPrizeLectureAward2012.aspx |website=UCLH Biomedical Research Centre (BRC) |access-date=30 October 2021 |archive-url=https://web.archive.org/web/20160202002158/http://www.uclh.nhs.uk/Research/BRC/News/Pages/KarolinskaInstitutetAnnualPrizeLectureAward2012.aspx |archive-date=2 February 2016 |date=2 February 2016}}</ref> <br /> 2011: WHO Stop TB Partnership, Kochon Foundation Prize and Medal<ref name="koch">{{cite web |title=Stop TB Partnership {{!}} 2011 Award Winner |url=http://www.stoptb.org/global/awards/kochon/awardees/2011.asp |website=www.stoptb.org |access-date=30 October 2021 |language=en}}</ref> <br /> 2000: The Albert Chalmers Medal<ref>RSTMH. {{cite web|url=https://rstmh.org/awards/medals/list-past-medal-holders |title=List of past medal holders RSTMH |date=7 February 2011 |access-date=23 November 2014 |archive-url=https://web.archive.org/web/20141218191857/https://rstmh.org/awards/medals/list-past-medal-holders |archive-date=18 December 2014 }}, ''List of past medal holders'', 2013. Retrieved on 23 November 2014.</ref> <br /> 1999: Weber-Parkes Trust Medal<ref>RSTMH. {{cite web|url=http://rstmh.org/sites/default/files/Vol7No31999.pdf |title=Archived copy |access-date=23 November 2014 |archive-url=https://web.archive.org/web/20120713214258/http://www.rstmh.org/sites/default/files/Vol7No31999.pdf |archive-date=13 July 2012 }}, ''The Weber Parkes Trust Medal and Prize'', 199 Vol 7 No. 3-page 5. Retrieved on 23 November 2014.</ref> | spouse = Farzana Bhuta | children = | religion = | website = https://iris.ucl.ac.uk/iris/browse/profile?upi=AZUML60 <br/> http://www.unza-uclms.org/ }}
'''Sir Alimuddin Zumla''' (born 15 May 1955) is a British-Zambian professor of infectious diseases and international health at University College London Medical School, and a Consultant Infectious Diseases physician at UCLHospitals NHS Foundation Trust, London, UK.<ref>{{Cite web|title=Zumla Alimuddin {{!}} The AAS|url=https://www.aasciences.africa/fellow/zumla-alimuddin|access-date=2021-03-06|website=www.aasciences.africa}}</ref><ref>{{Cite journal|last=Lane|first=Richard|date=2022-01-29|title=Ali Zumla: respiratory medicine and global health supremo|journal=The Lancet|language=English|volume=399|issue=10323|page=427|doi=10.1016/S0140-6736(22)00116-7|issn=0140-6736|pmc=8797028|pmid=35093219}}</ref><ref>{{Cite web |title=Professor Sir Alimuddin Zumla |url=https://www.uclh.nhs.uk/our-services/find-consultant/professor-sir-alimuddin-zumla |access-date=2024-12-22 |website=University College London Hospitals NHS Foundation Trust |language=en}}</ref> He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections (including COVID-19 and Tuberculosis), pathogens with epidemic potential and diseases of poverty.<ref>{{citation|url=http://www.postzambia.com/post-print_article.php?articleId=5826|periodical=The Post Zambia|date=14 February 2010|access-date=12 April 2011|last=Kuwema|first=Moses|title=Zambian doctor in contention for prestigious British award|archive-url=https://web.archive.org/web/20120911072927/http://www.postzambia.com/post-print_article.php?articleId=5826|archive-date=11 September 2012}}</ref><ref name=":0" /> He is known for his leadership of infectious/tropical diseases research and capacity development activities.<ref name="profile">{{citation|url=https://iris.ucl.ac.uk/iris/browse/profile?upi=AZUML60|title=Prof Ali Zumla|publisher=University College London Institutional Research Information System|access-date=27 December 2012}}</ref> He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease.<ref name="knight">{{cite web |title=Alimuddin ZUMLA {{!}} Knights Bachelor {{!}} The Gazette |url=https://www.thegazette.co.uk/notice/2803364 |website=The Gazette}}</ref> In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division.<ref>{{Cite web|date=2020-08-23|title=ZAMBIAN PROFESSOR BAGS INTERNATIONAL AWARD ~|url=https://www.znbc.co.zm/news/zambian-professor-bags-international-award/|access-date=2020-11-12|language=en-GB}}</ref> In 2024, for the seventh consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers.<ref name="clari2018">{{cite web |title=Professor Sir Ali Zumla cited in global list of influential researchers |url=https://www.ucl.ac.uk/infection-immunity/news/2018/nov/professor-sir-ali-zumla-cited-global-list-influential-researchers |website=UCL Division of Infection and Immunity |access-date=30 October 2021 |language=en |date=30 November 2018}}</ref><ref name="Clari2019">{{cite web |title=Professor Sir Ali Zumla cited in 2019 global list of influential researchers |url=https://www.ucl.ac.uk/infection-immunity/news/2019/nov/professor-sir-ali-zumla-cited-2019-global-list-influential-researchers |website=UCL Division of Infection and Immunity |access-date=30 October 2021 |language=en |date=29 November 2019}}</ref><ref name="Clari2020">{{cite web |title=UCL academics recognised in annual global list of influential researchers |url=https://www.ucl.ac.uk/news/2020/nov/ucl-academics-recognised-annual-global-list-influential-researchers |website=UCL News |access-date=30 October 2021 |language=en |date=20 November 2020}}</ref><ref name="clari2021">{{cite web |title=Professor Sir Alimuddin Zumla named in annual global list of influential researchers |url=https://www.ucl.ac.uk/infection-immunity/news/2021/nov/professor-sir-alimuddin-zumla-named-annual-global-list-influential-researchers |website=Division of Infection and Immunity |access-date=8 June 2022 |ref=clari2021 |language=en |date=16 November 2021}}</ref><ref>{{Cite web |title=UCLH and UCL clinicians listed among world's most influential researchers |url=https://www.uclh.nhs.uk/news/uclh-and-ucl-clinicians-listed-among-worlds-most-influential-researchers |access-date=2022-11-16 |website=University College London Hospitals NHS Foundation Trust |language=en}}</ref><ref name=":2">{{Cite web |last=UCL |date=2024-12-18 |title=Quadruple Triumph For Professor Sir Alimuddin Zumla |url=https://www.ucl.ac.uk/infection-immunity/research/research-department-infection/lab-research-groups/centre-clinical-microbiology/ccm-1 |access-date=2024-12-19 |website=Division of Infection and Immunity |language=en}}</ref><ref>{{Cite web |date=2023-11-15 |title=Web of Science |url=https://www.webofscience.com/wos/?app=wos&mode=Nextgen&path=/wos/author/record/ABA-8208-2020&IsProductCode=Yes&Init=Yes&DestApp=UA&Func=Frame&action=transfer&SrcApp=CR&locale=en&SID=USW2EC0BD3PVSkGTLh5ClGaG9Brj6 |access-date=2023-11-15 |archive-url=https://web.archive.org/web/20231115160635/https://www.webofscience.com/wos/?app=wos&mode=Nextgen&path=/wos/author/record/ABA-8208-2020&IsProductCode=Yes&Init=Yes&DestApp=UA&Func=Frame&action=transfer&SrcApp=CR&locale=en&SID=USW2EC0BD3PVSkGTLh5ClGaG9Brj6 |archive-date=15 November 2023 }}</ref> In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.<ref name="twas1">{{cite web |title=TWAS elects 58 new Fellows |url=https://twas.org/article/twas-elects-58-new-fellows |website=TWAS |date=3 November 2021 |language=en}}</ref><ref name="Twas2">{{cite web |title=Professor Sir Alimuddin Zumla receives fellowship from prestigious World Academy of Sciences |url=https://www.ucl.ac.uk/infection-immunity/news/2021/nov/professor-sir-alimuddin-zumla-receives-fellowship-prestigious-world-academy-sciences |website=Division of Infection and Immunity |language=en |date=17 November 2021}}</ref> In 2024, he was elected Member of the prestigious Academy of Europe (Academia Europaea).<ref>{{Cite web |title=Academy of Europe: Zumla Alimuddin |url=https://www.ae-info.org/ae/Member/Zumla_Alimuddin |access-date=2024-12-22 |website=www.ae-info.org}}</ref>
==Early life== Alimuddin "Ali" Zumla was born in Northern Rhodesia (now Chipata, Eastern Province, Zambia).<ref name="COPM">{{citation|title=Editorial introduction: Section Editor Alimuddin Zumla|journal=Current Opinion in Pulmonary Medicine|date=May 2009|volume=15|issue=3|page=vii|doi=10.1097/MCP.0b013e32832a1d8a}}</ref> His parents Ismail and Aman Zumla were of Gujarati Indian origin.<ref>{{cite web |title=Bharuchi Vahora Patel – In London – Gujarati Writers' Guild UK |url=https://www.mahek.co.uk/gwg/publications/bharuchi-vahora-patel/in-london/ |website=www.mahek.co.uk}}</ref> He resided in the Kamwala district of Lusaka. He did his early education at the Lotus Primary School and Prince Philip Secondary School (now Kamwala Secondary School) in Lusaka, and his medical training at the University of Zambia's School of Medicine.<ref>{{cite web |title=Zambia: Kamwala Boy Zumla Leads Fight Against Tuberculosis On World TB Day Launch |url=https://allafrica.com/stories/200603240197.html |website=allafrica.com |publisher=Times of Zambia |access-date=30 October 2021}}</ref> As a teenager, he declined a Rhodes Scholarship in order to pursue medical training in Zambia.<ref name=":1">{{Cite journal|last=Kirby|first=Tony|date=April 2013|title=Alimuddin Zumla: infectious diseases guru and survivor|journal=The Lancet Infectious Diseases|volume=13|issue=4|page=301|doi=10.1016/S1473-3099(13)70045-8|issn=1474-4457|pmid=23531387}}</ref>
In 1980, Zumla moved to London to pursue an MSc in tropical medicine at the University of London.<ref name="COPM"/> In 1982, he contracted life-threatening tuberculous meningitis, and was told that he would never walk again, but went on to recover and return to work a year and a half later despite disabling and painful neurological sequelae resulting from his meningitis.<ref name=":1" /><ref>{{Cite journal |date=June 2003 |title=Alimuddin Zumla |url=https://linkinghub.elsevier.com/retrieve/pii/S0140673603136501 |journal=The Lancet |language=en |volume=361 |issue=9374 |page=2092 |doi=10.1016/S0140-6736(03)13650-1|s2cid=54417914 |url-access=subscription }}</ref> He went on to pursue doctoral studies on leprosy human monoclonal antibodies at the London School of Hygiene & Tropical Medicine, where his 1987 dissertation (advised by Keith McAdam) merited him the Alan Woodruff Medal.<ref name="COPM"/><ref name="BTMIH">{{citation|title=The Weber Parkes Trust Medal and Prize |page=5 |journal=Bulletin of Tropical Medicine and International Health |volume=7 |number=3 |issn=1356-0832 |url=http://www.rstmh.org/sites/default/files/Vol7No31999.pdf |year=1999 |archive-url=https://web.archive.org/web/20120713214258/http://www.rstmh.org/sites/default/files/Vol7No31999.pdf |archive-date=13 July 2012 }}</ref><ref>{{citation|last=Zumla|first=Alimuddin|year=1987|series=PhD dissertation|publisher=London School of Tropical Medicine and Hygiene|title=Characterisation of human monoclonal antibodies to phenolic glycolipid-1 from patients with leprosy and production of their anti-idiotypes}}. See library record [https://archive.today/20120630204727/http://193.63.81.241/record=b1533167~S16 here].</ref>
==Career== Zumla spent a year at the London School of Hygiene and Tropical Medicine gaining the MSc degree in Clinical Tropical Diseases with a distinction and the Murgratroyd Prize. He subsequently worked at The Royal Northern and Royal Free Hospitals under the mentorship of David Geraint James obtaining his Membership of The Royal College of Physicians of London.{{citation needed|date=November 2018}}
After doing a PhD between 1985 and 1987, Zumla worked as infectious diseases registrar and at the Rush Green Regional Hospital for Infectious Diseases in Romford under Ming Yong and Mervyn Medlock. Whilst working at Rush Green Hospital, he identified and notified the first cases of the 1988 Legionnaires' Diseases outbreak which he traced back to Broadcasting House, BBC, central London.<ref name="ZumlaWeyell1988">{{cite journal|last1=Zumla|first1=A.|title=Legionnaires' Disease: Early Lessons from 1988 London Outbreak|last2=Weyell|first2=R.|last3=Tettmar|first3=R.E.|journal=The Lancet|volume=331|issue=8597|year=1988|page=1275|issn=0140-6736|doi=10.1016/S0140-6736(88)92089-2|pmid=2897531|s2cid=33343923}}</ref>
Zumla subsequently spent four years in a senior registrar/honorary lecturer position at the Hammersmith Hospital, Royal Postgraduate Medical School in London under Sir Robert Lechler, and then two years at the University of Texas Center for Infectious Diseases working with Herbert DuPont.<ref name="COPM"/><ref name="BTMIH"/><ref name="BMJ">{{citation|title=BMJ Group Lifetime Achievement Award: Professor Alimuddin Zumla|journal=BMJ|date=December 2009|volume=339|doi=10.1136/bmj.b5574|article-number=b5574|s2cid=220109881}}</ref> He then returned to his native Zambia to work on AIDS-related opportunistic infections at the University Teaching Hospital in Lusaka before moving to University College London in 1994.<ref name="BTMIH"/>
In 2003, there were media reports about a paper of Zumla's in ''The Lancet'' discussing a new test developed by a team he led for monitoring CD4 immune cell counts based on dried blood samples.<ref>{{citation|url=https://news.bbc.co.uk/2/hi/health/3227257.stm|periodical=BBC News|date=31 October 2003|access-date=12 April 2010|title=Paper test 'could help HIV care'}}</ref> Such counts are used in monitoring AIDS patients taking antiretroviral drug treatments; Zumla's subsequent work has led to development and evaluation of a range of rapid, cheap and more accessible diagnostic tests for TB and respiratory infections for use on patients in developing countries.<ref>{{citation|periodical=Nature News|last=Pearson|first=Helen|date=31 October 2003|doi=10.1038/news031027-11|title=Cheap test monitors HIV drugs: Dried blood spots could track developing world treatment success}}</ref><ref>{{citation|date=2 November 2003|access-date=12 April 2011|url=http://www.theage.com.au/articles/2003/11/02/1067708054834.html|title=New blood test boost for HIV drive|periodical=The Age}}</ref>
Zumla was the guest editor of the Lancet TB Series which addressed key issues around TB treatment and diagnosis. The launch was held at the World Health Organisation (WHO) in Geneva on 18 May 2010.<ref>{{Cite web |last=UCL |date=2010-05-19 |title=UCL plays key role in Lancet TB series |url=https://www.ucl.ac.uk/news/2010/may/ucl-plays-key-role-lancet-tb-series |access-date=2023-05-21 |website=UCL News |language=en}}</ref> {{As of|2011}}, Zumla is the director of the Centre for Infectious Diseases and International Health at University College London Medical School, as well as a consultant in infectious diseases at University College Hospital. His research interests include tuberculosis (particularly drug clinical trials, biomarkers, MDR-TB and TB in London), HIV/AIDS, tropical diseases, respiratory infections (and rapid diagnostics thereof), endocarditis, biomarkers, and transrenal DNA.<ref>{{cite web |title=Professor Sir Alimuddin Zumla: University College London Hospitals NHS Foundation Trust |url=https://www.uclh.nhs.uk/our-services/find-consultant/professor-sir-alimuddin-zumla |website=www.uclh.nhs.uk |access-date=30 October 2021 |language=en}}</ref>
Zumla's work focuses on improving global health, especially for disadvantaged populations, with an emphasis on assisting poorer and disadvantaged peoples of the world. He established and directs a multi-country collaboration with several African, Middle Eastern, European and United States institutions on collaborative research and training program on TB and HIV/AIDS.<ref name="profile"/><ref name="koch"/> Zumla and his collaborators have set up research and training programs in Africa, focusing attention on development of local infrastructure and capacity development.<ref>{{citation|url=http://www.unza-uclms.org/|title=Introduction|publisher=University of Zambia – University College London Medical School Research and Training Programme|access-date=27 December 2012}}</ref> Several of his doctoral students now occupy academic positions in institutions in Africa.<ref name="COPM"/>
Zumla has established north–south partnerships for TB research. His collaborations span five countries in Europe and 10 in sub-Saharan Africa, where he leads several multi-country research projects. His team's research findings have contributed to the development of WHO's management guidelines on treatment and prevention of TB and TB/HIV, and to improvements in the care of patients worldwide.<ref name="UCL20111102">{{citation|url=http://www.ucl.ac.uk/news/news-articles/1111/11110102-zumla-TB-prizes|title=UCL Professor wins trio of prizes for TB work|publisher=University College London|date=2 November 2011|access-date=27 December 2012}}</ref>
In 2014, together with colleagues from Public Health England, World Health Organization, London School of Hygiene and Tropical Medicine, and the Middle East, Zumla co-led The Lancet series on Mass Gatherings Medicine which was launched at the World Health Assembly of Ministers of Health in Geneva. This was a Series of reports about different mass gatherings: the London 2012 Olympic and Paralympic Games; the 2012 European Football Championship finals, hosted jointly by Poland and Ukraine; and the 2012 and 2013 Hajj. These reports set out the planning and surveillance systems used to monitor public health risks, and describe the public health experiences and lessons learnt for the planning of future events.<ref>The Lancet. [http://www.thelancet.com/series/mass-gatherings-medicine], ''Mass Gatherings Medicine'', 21 May 2014. Retrieved on 26 November 2014.</ref> In 2024 a study published in The Lancet co-led by Sir Zumla and Dr Brian McCloskey of Chatham House –involving an international group of public health experts from the UK, Japan, Switzerland and the US outlines how mass gathering events can be held safely even in the context of an infectious disease pandemic.<ref>{{Cite web |title=Olympics held during Covid pandemic show how mass gatherings events can be safe |url=https://www.uclh.nhs.uk/news/olympics-held-during-covid-pandemic-show-how-mass-gatherings-events-can-be-safe#:~:text=Olympics%20held%20during%20Covid%20pandemic%20show%20how%20mass%20gatherings%20events%20can%20be%20safe,-14%20February%202024&text=A%20new%20study%20published%20last,Olympics%20(held%20in%202021). |access-date=2024-12-22 |website=University College London Hospitals NHS Foundation Trust |language=en}}</ref>
Zumla played a lead role in defining the etiology, epidemiology, virology, pathogenesis, mode of transmission, diagnosis, management and infection control measures of Middle East respiratory syndrome coronavirus.<ref>UCL News. [http://www.ucl.ac.uk/news/news-articles/0613/19062013-Researchers-unravel-MERS-Coronavirus-transmission-Zumla ''Researchers shed light on MERS Coronavirus transmission''], 19 June 2013. Retrieved on 26 November 2014.</ref><ref>{{Cite journal | last1 = Assiri | first1 = A. | last2 = McGeer | first2 = A. | last3 = Perl | first3 = T. M. | last4 = Price | first4 = C. S. | last5 = Al Rabeeah | first5 = A. A. | last6 = Cummings | first6 = D. A. T. | last7 = Alabdullatif | first7 = Z. N. | last8 = Assad | first8 = M. | last9 = Almulhim | first9 = A. | last10 = Makhdoom | first10 = H. | last11 = Madani | first11 = H. | last12 = Alhakeem | first12 = R. | last13 = Al-Tawfiq | first13 = J. A. | last14 = Cotten | first14 = M. | last15 = Watson | first15 = S. J. | last16 = Kellam | first16 = P. | last17 = Zumla | first17 = A. I. | last18 = Memish | first18 = Z. A. | title = Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus | doi = 10.1056/NEJMoa1306742 | journal = New England Journal of Medicine | volume = 369 | issue = 5 | pages = 407–416 | year = 2013 | pmid = 23782161| pmc = 4029105}}</ref> His publications have emphasised the importance of development of new therapeutics and vaccines.<ref>{{Cite journal |last1=Azhar |first1=Esam I. |last2=Velavan |first2=Thirumalaisamy P. |last3=Rungsung |first3=Ikrormi |last4=Traore |first4=Tieble |last5=Hui |first5=David S. |last6=McCloskey |first6=Brian |last7=El-Kafrawy |first7=Sherif A. |last8=Zumla |first8=Alimuddin |date=June 2023 |title=Middle East respiratory syndrome coronavirus-a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins |journal=International Journal of Infectious Diseases |volume=131 |pages=87–94 |doi=10.1016/j.ijid.2023.03.046 |issn=1878-3511 |pmid=36996998|pmc=10050196 }}</ref><ref>{{Cite web |title=zumla mers - Search Results - PubMed |url=https://pubmed.ncbi.nlm.nih.gov/?term=zumla+mers&sort=date&size=200 |access-date=2024-12-22 |website=PubMed |language=en}}</ref>
Zumla has served on numerous international advisory groups. He was Member of Court of Governors of the London School of Hygiene and Tropical Medicine (2007–2014), under the directorship of Sir Andrew Haines.<ref name="LSHTMMahathir">{{cite web |title=Professor Sir Alimuddin Zumla honoured with 2020 Mahathir Science Award Winner in Tropical Medicine |url=https://www.lshtm.ac.uk/aboutus/alumni/blogs/2020/professor-sir-alimuddin-zumla-honoured-2020-mahathir-science-award-winner-tropical-medicine |website=LSHTM |language=en}}</ref> He was vice president of the Royal Society of Tropical Medicine and Hygiene (2003–2005).<ref name="2003RSTMStructure">{{cite web |title=2003 Structure, Royal Society of Tropical Medicine and Hygiene |url=http://www.rstmh.org/English/structureEnglish.html |date=4 December 2003|archive-url=https://web.archive.org/web/20031204044813/http://www.rstmh.org/English/structureEnglish.html |archive-date=4 December 2003 }}</ref><ref name="2005RSTMStructure">{{cite web |title=2005 Structure, Royal Society of Tropical Medicine and Hygiene |url=http://www.rstmh.org/English/structureEnglish.html |date=6 February 2005|archive-url=https://web.archive.org/web/20050206044709/http://www.rstmh.org/English/structureEnglish.html |archive-date=6 February 2005 }}</ref> He served as Vice Chair of the Strategic Advisory Group to the European and Developing Countries Clinical Trials Partnership(2014–2016)<ref>{{citation|url=http://www.edctp.org/get-know-us/scientific-advisory-committee/|title=EDCTP Strategic Advisory Committee|work=Members of the Strategic Advisory Committee|access-date=28 March 2015}}</ref>
On 7 April 2015, at an inaugural meeting in Cape Town, South Africa, Zumla and Markus Maeurer from Karolinska Institutet, Sweden led and established a new initiative, the Host-Directed Therapies Network (HDT-NET) consortium of 64 global partners to tackle global infectious diseases threats of multi-drug resistant TB and antimicrobial resistance.<ref name="ZumlaChakaya2015">{{cite journal|last1=Zumla|first1=Alimuddin|last2=Chakaya|first2=Jeremiah|last3=Hoelscher|first3=Michael|last4=Ntoumi|first4=Francine|last5=Rustomjee|first5=Roxana|last6=Vilaplana|first6=Cristina|last7=Yeboah-Manu|first7=Dorothy|last8=Rasolof|first8=Voahangy|last9=Munderi|first9=Paula|last10=Singh|first10=Nalini|author11-link=Eleni Aklillu|last11=Aklillu|first11=Eleni|last12=Padayatchi|first12=Nesri|last13=Macete|first13=Eusebio|last14=Kapata|first14=Nathan|last15=Mulenga|first15=Modest|last16=Kibiki|first16=Gibson|last17=Mfinanga|first17=Sayoki|last18=Nyirenda|first18=Thomas|last19=Maboko|first19=Leonard|last20=Garcia-Basteiro|first20=Alberto|last21=Rakotosamimanana|first21=Niaina|last22=Bates|first22=Matthew|last23=Mwaba|first23=Peter|last24=Reither|first24=Klaus|last25=Gagneux|first25=Sebastien|last26=Edwards|first26=Sarah|last27=Mfinanga|first27=Elirehema|last28=Abdulla|first28=Salim|last29=Cardona|first29=Pere-Joan|last30=Russell|first30=James B.W.|last31=Gant|first31=Vanya|last32=Noursadeghi|first32=Mahdad|last33=Elkington|first33=Paul|last34=Bonnet|first34=Maryline|last35=Menendez|first35=Clara|last36=Dieye|first36=Tandakha N.|last37=Diarra|first37=Bassirou|last38=Maiga|first38=Almoustapha|last39=Aseffa|first39=Abraham|last40=Parida|first40=Shreemanta|last41=Wejse|first41=Christian|last42=Petersen|first42=Eskild|last43=Kaleebu|first43=Pontiano|last44=Oliver|first44=Matt|last45=Craig|first45=Gill|last46=Corrah|first46=Tumena|last47=Tientcheu|first47=Leopold|last48=Antonio|first48=Martin|last49=Rao|first49=Martin|last50=McHugh|first50=Timothy D.|last51=Sheikh|first51=Aziz|last52=Ippolito|first52=Giuseppe|last53=Ramjee|first53=Gita|last54=Kaufmann|first54=Stefan H. E.|last55=Churchyard|first55=Gavin|last56=Steyn|first56=Andrie|last57=Grobusch|first57=Martin|last58=Sanne|first58=Ian|last59=Martinson|first59=Neil|last60=Madansein|first60=Rajhmun|last61=Wilkinson|first61=Robert J.|last62=Mayosi|first62=Bongani|last63=Schito|first63=Marco|last64=Wallis|first64=Robert S.|last65=Maeurer|first65=Markus|title=Towards host-directed therapies for tuberculosis|journal=Nature Reviews Drug Discovery|volume=14|issue=8|year=2015|pages=511–512|issn=1474-1776|doi=10.1038/nrd4696|pmid=26184493|s2cid=7418745|url=http://openaccess.city.ac.uk/12311/1/fv%20Draft%20Commentary%20on%20HDT%20for%20Nature%20Reviews%20Drugs%20Discovery%20%283%29.pdf}}</ref>
In 2020, Zumla was cited as a leading expert on the COVID-19 pandemic.<ref name=":0">{{Cite web|last=Halpin|first=Hayley|title=Belfast researchers launch clinical trial for Covid-19 patients using umbilical cord cells|url=https://www.thejournal.ie/queens-university-coronavirus-clinical-trial-5068763-Apr2020/|access-date=2020-06-24|website=TheJournal.ie|date=7 April 2020 |language=en}}</ref><ref>{{Cite web|date=2020-05-15|title=Coronavirologists: Where to find the world's top experts right now|url=https://www.studyinternational.com/news/coronavirologists-leading-world/|access-date=2020-06-24|website=Study International|language=en-GB}}</ref>
In 2021 Zumla was elected as Fellow of The World Academy of Sciences whose principal aim is to promote scientific capacity and excellence for sustainable development in developing countries.<ref name="twas1"/><ref name="Twas2"/>
In 2022 Zumla was profiled in the Lancet.<ref name="lancetprofile2022">{{cite journal |last1=Lane |first1=R |title=Ali Zumla: respiratory medicine and global health supremo. |journal=Lancet |date=29 January 2022 |volume=399 |issue=10323 |page=427 |doi=10.1016/S0140-6736(22)00116-7 |pmid=35093219 |pmc=8797028 |ref=lancetprofile2022}}</ref> On 12 October 2022, the Royal Society of Tropical Medicine and Hygiene awarded Zumla the Sir Patrick Manson Medal, their highest mark of distinction. Zumla is the first ethnic minority recipient of this award since its conception in 1923.<ref name="RSTMH_manson" /><ref name="rstmh_past">{{cite web |title=Sir Patrick Manson Medal {{!}} RSTMH |url=https://rstmh.org/medals-awards/sir-patrick-manson-medal |website=rstmh.org |access-date=16 October 2022 |ref=rstmh_past}}</ref>
In 2024, together with colleagues from UK-Health security Agency, London School of Hygiene and Tropical Medicine, WHO and other global ONE-HEALTH investigators, Zumla co-led The Lancet Series on One Health and Global Health Security. This was a four-paper series exploring the adoption of One Health approaches to improve health security and include an analysis of the current landscape of preventive, surveillance, and response measures in outbreak situations of emerging and re-emerging zoonotic infectious diseases with epidemic potential, antimicrobial resistance, environmental and chemical hazards and natural disasters.<ref>{{Cite web |title=The Lancet Series on One Health and Global Health Security |url=https://www.thelancet.com/series/one-health-and-global-health-security |archive-url=https://web.archive.org/web/20230525121612/https://www.thelancet.com/series/one-health-and-global-health-security |archive-date=2023-05-25 |access-date=2024-12-23 |website=www.thelancet.com |language=en}}</ref> On November 26 Zumla was awarded the Long Service Lifetime Achievement award by the UCLHospitals NHS Fiundation Trust.<ref name=":2" />
==Awards==
{{Awards table|3}} |- ! scope="row" | 1999 | Weber Parkes Trust Medal and Prize | Royal College of Physicians of London | {{won}} | Awarded triennially from 1897 for work in the prevention and cure of tuberculosis. | <ref name="BTMIH"/> |- ! scope="row" | 2000 | Albert Chalmers Medal | Royal Society of Tropical Medicine and Hygiene | {{won}} | Recognises researchers in tropical medicine or global health who demonstrate evidence of mentoring and professional development of junior investigators, and other forms of capacity building. | <ref name="ChalmerMed">{{cite web |title=Previous medal winners |url=http://rstmh.org/awards/previous-medal-winners#Chalmers%20Medal |website=The Royal Society of Tropical Medicine and Hygiene |date=6 August 2014 |archive-url=https://web.archive.org/web/20170123204106/http://rstmh.org/awards/previous-medal-winners#Chalmers%20Medal |access-date=30 October 2021|archive-date=23 January 2017 }}</ref> |- ! scope="row" | 2003 | Windrush Award for Academic Achievement | African Caribbean Achievement Project | {{won}} | The awards recognise talent and achievement in the African Caribbean, Asian and Oriental communities. | <ref name="windrush">{{cite web |title=UCL professor wins prestigious Windrush Achievement Award |url=https://www.ucl.ac.uk/news/2003/oct/ucl-professor-wins-prestigious-windrush-achievement-award |website=UCL News |access-date=30 October 2021 |language=en |date=15 October 2003}}</ref> |- ! scope="row" | 2005 | Ibn Sina Award for Medicine | The Muslim News Awards for Excellence | {{won}} | Professional of the year for medicine. | <ref>{{citation|url=http://www.muslimnews.co.uk/paper/index.php?article=1880|periodical=Muslim News|date=25 February 2005|access-date=12 April 2011|title=Muslim News Awards for Excellence 2005 Shortlist|archive-url=https://web.archive.org/web/20120825211929/http://www.muslimnews.co.uk/paper/index.php?article=1880|archive-date=25 August 2012}}</ref> |- ! scope="row" | 2011 | Science Award | UK India International Foundation | {{won}} | for outstanding achievements in science by a professional with origins in India. | <ref name="ucltrio">{{cite web |title=UCL Professor wins trio of prizes for TB work |url=https://www.ucl.ac.uk/news/2011/nov/ucl-professor-wins-trio-prizes-tb-work |website=UCL News |access-date=30 October 2021 |language=en |date=1 November 2011}}</ref> |- ! scope="row" | 2011 | Spinoza Leerstoel award | University of Amsterdam | {{won}} | for "Outstanding research & capacity development achievements in the global fight against TB and TB/HIV/AIDS" | <ref name="ucltrio" /> |- ! scope="row" | 2011 | Kochon Prize and Medal | World Health Organisation (WHO) Stop TB Partnership | {{won}} | Announced at the opening ceremony of the World Conference of the International Union Against Tuberculosis and Lung Disease (the Union) in Lille | <ref name="koch" /><ref name="ucltrio" /><ref>{{cite web |title=Stop TB Partnership {{!}} Stop TB Partnership and Kochon Foundation announce recipients of 2011 award for distinguished achievements in combating tuberculosis |url=http://www.stoptb.org/news/stories/2011/ns11_070.asp |website=www.stoptb.org |language=en}}</ref> |- ! scope="row" | 2012 | Annual Science Prize | Karolinska Institutet | {{won}} | For outstanding outputs in global health and infectious diseases | <ref name="Karolinska" /><ref>{{cite web |title=People 2012 |url=https://www.ucl.ac.uk/news/people-2012 |website=UCL News |access-date=30 October 2021 |language=en |date=2 July 2018}}</ref> |- ! scope="row" | 2012 | Grand Commander of the Order of Distinguished Services First Division | Republic of Zambia | {{won}} | The highest Zambian civilian award. Bestowed on Zumla on the 48th anniversary of Zambia's Independence (October 2012) by then Zambian president Michael Sata for his outstanding contributions to infectious diseases research in sub-Saharan Africa, development of Zambia's health sector, and training of numerous health personnel. | <ref>{{cite web |title=Zambia: Prof Zumla Dedicates Award to Uth, Moh Staff |url=https://allafrica.com/stories/201210270347.html |website=allafrica.com |publisher=Times of Zambia |access-date=30 October 2021}}</ref><ref>{{cite web |title=Zambia: Sata Honours Wives of Freedom Fighters |url=https://allafrica.com/stories/201210251144.html |website=allafrica.com |publisher=Times of Zambia |access-date=30 October 2021}}</ref> |- ! scope="row" | 2016 | Honorary doctorate | Karolinska Institutet | {{won}} | To individuals for their important scientific achievements or significant contributions to the university or humanity at large. | <ref name="UCL20111102"/><ref>{{cite web |title=Honorary Doctors of Medicine at Karolinska Institutet 1910-2020 {{!}} Karolinska Institutet |url=https://ki.se/en/about/honorary-doctors-of-medicine-at-karolinska-institutet-1910-2020 |website=ki.se |access-date=30 October 2021 |language=en}}</ref> |- ! scope="row" | 2016 | European and Developing Countries Clinical Trials Partnership prize | European and Developing Countries Clinical Trials Partnership | {{won}} | Won by a research consortium led by Zumla. Presented by Zambian President Edgar Lungu. | <ref>{{Cite web|url=http://www.uclhospitals.brc.nihr.ac.uk/investigators/news/university-zambia-university-college-london-medical-school-awarded-outstanding|title=University of Zambia-University College London Medical School awarded Outstanding Research Team {{!}} UCLH Biomedical Research Centre|website=www.uclhospitals.brc.nihr.ac.uk|date=11 November 2016 |access-date=2016-11-11}}</ref> |- ! scope="row" | 2017 | Senior investigator award | National Institute for Health and Care Research | {{won}} | NIHR Senior Investigators are 'among the most prominent and prestigious researchers' and the most outstanding leaders within the NIHR Faculty. Senior Investigators are appointed from NIHR Investigators through annual competitions informed by the advice of an international panel of experts. | <ref>{{Cite web|url=http://www.nihr.ac.uk/our-faculty/documents/Senior%20Investigators-%20list%20of%20tenth%20round%20appointments%20March%202017.pdf|title=NIHR Senior Investigators 2016|website=|archive-url=https://web.archive.org/web/20170329144714/http://www.nihr.ac.uk/our-faculty/documents/Senior%20Investigators-%20list%20of%20tenth%20round%20appointments%20March%202017.pdf|archive-date=29 March 2017}}</ref> |- ! scope="row" | 2018 | Annual global list of influential researchers | Clarivate Analytics, Web of Science | {{won}} | World's top 1% most cited researchers. | <ref name="clari2018" /> |- ! scope="row" | 2019 | Annual global list of influential researchers | Clarivate Analytics, Web of Science | {{won}} | World's top 1% most cited researchers. | <ref name="Clari2019" /> |- ! scope="row" | 2020 | Annual global list of influential researchers | Clarivate Analytics, Web of Science | {{won}} | World's top 1% most cited researchers. | <ref name="Clari2020" /> |- ! scope="row" | 2020 | Mahathir Science Award in Tropical Medicine | Mahathir Science Award Foundation, Academy of Sciences Malaysia | {{won}} | A Malaysian science prize awarded to those who have made outstanding contributions to tropical sciences. | <ref name="maha" /><ref>{{Cite web|last=UCL|date=2020-08-19|title=International infectious diseases award for UCL professor|url=https://www.ucl.ac.uk/news/2020/aug/international-infectious-diseases-award-ucl-professor|access-date=2021-06-16|website=UCL News|language=en}}</ref> |- ! scope="row" | 2020 | Dr Pascoal Mocumbi prize | EU-EDCTP | {{won}} | Awarded to senior scientists, policy-makers or advocates for health and research | <ref name="pasc" /><ref>{{cite web |title=Dr Pascoal Mocumbi Prize |url=http://www.edctp.org/prizes/dr-pascoal-mocumbi-prize/# |website=EDCTP |access-date=30 October 2021}}</ref><ref name="RCPPascal">{{cite web |last1=Pathologists |first1=The Royal College of |title=College fellow awarded prestigious international prize for advancing health research and capacity development in Africa |url=https://www.rcpath.org/discover-pathology/news/college-fellow-international-prize.html |website=www.rcpath.org |access-date=22 June 2022 |ref=RCPPascal}}</ref> |- ! scope="row" | 2021 | Annual global list of influential researchers | Clarivate Analytics, Web of Science | {{won}} | World's top 1% most cited researchers. | <ref name="clari2021" /> |- ! scope="row" | 2022 | Senior investigator award (Renewal) | National Institute for Health and Care Research | {{won}} | NIHR Senior Investigators are 'among the most prominent and prestigious researchers' and the most outstanding leaders within the NIHR Faculty. Senior Investigators are appointed from NIHR Investigators through annual competitions informed by the advice of an international panel of experts. | <ref name="NIHR2022">{{cite web |title=NIHR Senior Investigators 2022 |url=https://www.nihr.ac.uk/documents/nihr-senior-investigators-2022/29866 |website=www.nihr.ac.uk |access-date=8 June 2022 |ref=NIHR2022 |language=EN}}</ref> |- ! scope="row" | 2022 | Annual global list of influential researchers | Clarivate Analytics, Web of Science | {{won}} | World's top 1% most cited researchers. | <ref name="clari2021" /> |- ! scope="row" | 2022 | Sir Patrick Manson Medal | Royal Society of Tropical Medicine and Hygiene | {{won}} | The Sir Patrick Manson Medal is the Royal Society of Tropical Medicine and Hygiene's highest mark of distinction. It is awarded once every three years to senior experts whose contribution to tropical medicine or hygiene is considered to merit the honour most. | <ref name="RSTMH_manson">{{cite web |title=RSTMH Medals and Awards winners 2022 {{!}} RSTMH |url=https://rstmh.org/news-blog/news/rstmh-medals-and-awards-winners-2022 |website=rstmh.org |access-date=16 October 2022 |ref=RSTMH_manson}}</ref> |- ! scope="row" | 2023 | Annual global list of influential researchers | Clarivate Analytics, Web of Science | {{won}} | World's top 1% most cited researchers. | <ref>{{Cite web |title=UCL Academics Feature in Global List of Influential Researchers |url=https://www.miragenews.com/ucl-academics-feature-in-global-list-of-1125514/ |access-date=2023-12-05 |website=Mirage News |language=en-AU}}</ref> {{end}}
==Quotes== {{quote box|align=left|width=33%|quote="Everyone should hold hands together and move forward in the fight against killer infectious diseases" |<ref>{{Cite journal | doi = 10.1097/MCP.0000000000000056| title = Editorial introduction| journal = Current Opinion in Pulmonary Medicine| volume = 20| issue = 3| pages = v–vi| year = 2014 | doi-access = free}}</ref>}} {{Clear}}
==Selected works== Zumla has authored more than 700 publications and edited/published 21 medical textbooks, three of which are globally acknowledged classics: ''Manson's Tropical Diseases'' 21st and 22nd editions, ''Tuberculosis: A Comprehensive Clinical Reference'' which involves 156 global TB experts writing 104 chapters on all aspects of paediatric and adult TB, and ''Granulomatous Disorders'' co-edited with D. G. James.<ref>{{PubMedAuthorSearch|Zumla|A}}</ref> {{Scholia}}
===Books=== * Zumla Alimuddin and Abubakar Ibrahim (Senior Editors). Editors: Miriam Orcutt, Clare Shortall, Sarah Walpole, Aula Abbara, Sylvia Garry , Rita Issa (2022). CLINICAL HANDBOOK OF REFUGEE HEALTH (2021) {{ISBN|9781138612884}}. Nov, 2021 CRC Press Taylor and Francis * Stefan HE Kaufmann, Eric Rubin, and Alimuddin Zumla. PERSPECTIVES IN MEDICINE (2015) Publisher: Cold Spring Harbour Press, USA. {{ISBN|978-1621820734}} * Zumla Alimuddin and Hui David. (2019). EMERGING AND RE-EMERGING INFECTIOUS DISEASES. Hardcover {{ISBN|9780323708456}} eBook {{ISBN|9780323708463}}. Elsevier Saunders, New York. * {{citation |title=Travel Medicine, An Issue of Infectious Disease Clinics |first1=Alimuddin |last1=Zumla |first2=Ronald H. |last2=Behrens |first3=Ziad A. |last3=Memish |year=2012 |edition=1st |isbn=978-1-4557-4898-3 |location=Philadelphia, PA |publisher=Saunders |oclc=815361562}} * Zumla Alimuddin and Keiser Jennifer (Editors). TROPICAL DISEASES (2012) Publishers: Elsevier Saunders publishers, New York. {{ISBN|978-1-4557-3880-9}}. * Zumla Alimuddin, Yew WWing-Wai and Hui David (2011). EMERGING RESPIRATORY INFECTIONS IN THE 21ST CENTURY. (2011). Publishers: Elsevier Saunders publishers, New York. {{ISBN|1437724604}}. * Zumla Alimuddin, and Schaaf Simon. Clinics in Chest Medicine. TUBERCULOSIS. (2011). ( {{ISBN|9781437718041}}). Publisher: Elsevier publishers, London, New York. * {{citation|editor-first=H. Simon|editor-last=Schaaf|editor2-first=Alimuddin|editor2-last=Zumla|title=Tuberculosis: a comprehensive clinical reference|isbn=978-1-4160-3988-4|year=2009|publisher=Saunders/Elsevier}} * {{citation|title=Tuberculosis: An Issue of Clinics in Chest Medicine|first1=Alimuddin|last1=Zumla|first2=H. Simon|last2=Schaaf|year=2009|publisher=Elsevier – Health Sciences Division|isbn=978-1-4377-1804-1}} * {{citation|editor-last=Cook|editor-first=Gordon C|editor2-last=Zumla|editor2-first=Alimuddin|title=Manson's Tropical Diseases|edition=22nd|publisher=Elsevier Harcourt Brace Publishing Group|location=London|year=2008|isbn=978-1-4160-4470-3}} * Gandy Matthew and Zumla Alimuddin. (2003). THE RETURN OF THE WHITE PLAGUE: GLOBAL POVERTY AND THE NEW TUBERCULOSIS. Publishers: Verso Books, London: (20 chapters with 49 international authors). {{ISBN|978-1859846698}} * Cook GC and Zumla A. Editors: (2003) MANSON'S TROPICAL DISEASES, 21st edition. Harcourt Brace Saunders Publishing Group, London {{ISBN|0702026409}}. * James D Geraint and Zumla Alimuddin. (1999) GRANULOMATOUS DISORDERS Publishers: Cambridge University Press, Cambridge, UK. (1999). {{ISBN|978-0521592215}} * {{citation|title=AIDS and respiratory medicine|first1=Alimuddin|last1=Zumla|first2=Margaret A.|last2=Johnson|first3=Robert|last3=Miller|year=1997|publisher=Chapman & Hall Medical|isbn=978-0-412-60140-8|url-access=registration|url=https://archive.org/details/aidsrespiratorym0000unse}}
===Journal papers=== * {{Cite journal |last1=Nachega |first1=Jean B. |author-link=Jean Nachega |last2=Sam-Agudu |first2=Nadia A. |last3=Mellors |first3=John W. |last4=Zumla |first4=Alimuddin |last5=Mofenson |first5=Lynne M. |date=2021-03-31 |title=Scaling Up Covid-19 Vaccination in Africa — Lessons from the HIV Pandemic |journal=New England Journal of Medicine |volume=385 |issue=3 |language=en |pages=196–198 |doi=10.1056/NEJMp2103313 |issn=0028-4793 |pmid=33789005 |pmc=8291168 |doi-access=free}} * {{Cite journal |last1=Carsetti |first1=Rita |last2=Quintarelli |first2=Concetta |last3=Quinti |first3=Isabella |last4=Piano Mortari |first4=Eva |last5=Zumla |first5=Alimuddin |last6=Ippolito |first6=Giuseppe |last7=Locatelli |first7=Franco |date=2020 |title=The immune system of children: the key to understanding SARS-CoV-2 susceptibility? |journal=The Lancet Child & Adolescent Health |language=en |volume=4 |issue=6 |pages=414–416 |doi=10.1016/S2352-4642(20)30135-8 |pmc=7202830 |pmid=32458804}} * {{Cite journal|last1=Zumla|first1=Alimuddin|last2=Hui|first2=David S|last3=Perlman|first3=Stanley|date=2015|title=Middle East respiratory syndrome|url= |journal=The Lancet|language=en|volume=386|issue=9997|pages=995–1007|doi=10.1016/S0140-6736(15)60454-8|pmc=4721578|pmid=26049252}} * {{Cite journal | doi = 10.1016/S0140-6736(13)62342-9| pmid = 24857700| title = London 2012 Olympic and Paralympic Games: Public health surveillance and epidemiology| journal = The Lancet| volume = 383| issue = 9934| pages = 2083–2089| year = 2014| last1 = McCloskey | first1 = B. | last2 = Endericks | first2 = T. | last3 = Catchpole | first3 = M. | last4 = Zambon | first4 = M. | last5 = McLauchlin | first5 = J. | last6 = Shetty | first6 = N. | last7 = Manuel | first7 = R. | last8 = Turbitt | first8 = D. | last9 = Smith | first9 = G. | last10 = Crook | first10 = P. | last11 = Severi | first11 = E. | last12 = Jones | first12 = J. | last13 = Ibbotson | first13 = S. | last14 = Marshall | first14 = R. | last15 = Smallwood | first15 = C. A. H. | last16 = Isla | first16 = N. | last17 = Memish | first17 = Z. A. | last18 = Al-Rabeeah | first18 = A. A. | last19 = Barbeschi | first19 = M. | last20 = Heymann | first20 = D. L. | last21 = Zumla | first21 = A. | pmc = 7138022 }} * {{cite journal | author = Zumla A., Raviglione M., Hafner R., Fordham, von Reyn C. | year = 2013 | title = Tuberculosis | journal = New England Journal of Medicine | volume = 368 | issue = 8| pages = 745–755 | doi = 10.1056/NEJMra1200894 | pmid=23425167}} * {{citation|title=Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ)|first1=Andrew J.|last1=Nunn|first2=Peter B.|last2=Mwaba|first3=Chifumbe|last3=Chintu|first4=Angela M.|last4=Crook|first5=Janet H.|last5=Darbyshire|first6=Yusuf|last6=Ahmed|first7=Alimuddin I.|last7=Zumla|doi=10.1111/j.1365-3156.2011.02731.x|pmid=21281407|journal=Tropical Medicine & International Health|volume=16|number=4|pages=518–526|date=April 2011|s2cid=31384786|doi-access=free}} * {{Cite journal | last1 = Griffiths | first1 = C. | last2 = Sturdy | first2 = P. | last3 = Brewin | first3 = P. | last4 = Bothamley | first4 = G. | last5 = Eldridge | first5 = S. | last6 = Martineau | first6 = A. | last7 = MacDonald | first7 = M. | last8 = Ramsay | first8 = J. | last9 = Tibrewal | first9 = S. | last10 = Levi | first10 = S. | last11 = Zumla | first11 = A. | last12 = Feder | first12 = G. | doi = 10.1016/S0140-6736(07)60707-7 | title = Educational outreach to promote screening for tuberculosis in primary care: A cluster randomised controlled trial | journal = The Lancet | volume = 369 | issue = 9572 | pages = 1528–34 | year = 2007 | pmid = 17482983| s2cid = 9170497 }} * {{citation|pmid=16546544|year=2006|last1=Perkins|first1=M. D.|last2=Roscigno|first2=G.|last3=Zumla|first3=A.|title=Progress towards improved tuberculosis diagnostics for developing countries|volume=367|issue=9514|pages=942–3|doi=10.1016/S0140-6736(06)68386-4|journal=The Lancet|s2cid=11903281}} * {{citation|pmid=16546520|year=2006|last1=Zumla|first1=A|last2=Mullan|first2=Z|title=Turning the tide against tuberculosis|volume=367|issue=9514|pages=877–8|doi=10.1016/S0140-6736(06)68355-4|journal=The Lancet|s2cid=20666586}} * {{Cite journal | last1 = Chintu | first1 = C. | last2 = Bhat | first2 = G. J. | last3 = Walker | first3 = A. S. | last4 = Mulenga | first4 = V. | last5 = Sinyinza | first5 = F. | last6 = Lishimpi | first6 = K. | last7 = Farrelly | first7 = L. | last8 = Kaganson | first8 = N. | last9 = Zumla | first9 = A. | last10 = Gillespie | first10 = S. H. | last11 = Nunn | first11 = A. J. | last12 = Gibb | first12 = D. M. | doi = 10.1016/S0140-6736(04)17442-4 | title = Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): A double-blind randomised placebo-controlled trial | journal = The Lancet | volume = 364 | issue = 9448 | pages = 1865–71 | year = 2004 | pmid = 15555666| s2cid = 503777 }} * {{citation|pmid=14602443|year=2003|last1=Mwaba|first1=P.|last2=Cassol|first2=S.|last3=Pilon|first3=R.|last4=Chintu|first4=C.|last5=Janes|first5=M.|last6=Nunn|first6=A.|last7=Zumla|first7=A.|title=Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients|volume=362|issue=9394|pages=1459–60|doi=10.1016/S0140-6736(03)14693-4|journal=The Lancet|s2cid=34623423}} * {{citation|pmid=14697808|year=2003|last1=Mwaba|first1=P.|last2=Cassol|first2=S.|last3=Nunn|first3=A.|last4=Pilon|first4=R.|last5=Chintu|first5=C.|last6=Janes|first6=M.|last7=Zumla|first7=A.|title=Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients|volume=362|issue=9401|pages=2067–8|doi=10.1016/S0140-6736(03)15103-3|journal=The Lancet|s2cid=21275947}} *{{citation|pmid=12383668|year=2002|last1=Chintu|first1=C.|last2=Mudenda|first2=V.|last3=Lucas|first3=S.|last4=Nunn|first4=A.|last5=Lishimpi|first5=K.|last6=Maswahu|first6=D.|last7=Kasolo|first7=F.|last8=Mwaba|first8=P.|last9=Bhat|first9=G.|last10=Terunuma|first10=H.|last11=Zumla|first11=A.|title=Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study|volume=360|issue=9338|pages=985–90|doi=10.1016/S0140-6736(02)11082-8|journal=The Lancet|s2cid=32379604}} * {{citation|pmid=12383985|year=2002|last1=Mwinga|first1=A.|last2=Nunn|first2=A.|last3=Ngwira|first3=B.|last4=Chintu|first4=C.|last5=Warndorff|first5=D.|last6=Fine|first6=P.|last7=Darbyshire|first7=J.|last8=Zumla|first8=A.|title=Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial|volume=360|issue=9339|pages=1050–5|doi=10.1016/S0140-6736(02)11141-X|journal=The Lancet|s2cid=20654344}}
=== Bibliographic databases=== * {{ORCID|orcid=0000-0002-5111-5735}} * {{Google scholar id|4_DvHm0AAAAJ}} * {{Scopus|7006170723}} * [https://pubmed.ncbi.nlm.nih.gov/?term=zumla+a&sort=pubdate&size=200 Search Results for author Zumla] on PubMed.
==References== {{Reflist}}
{{Authority control}}
{{DEFAULTSORT:Zumla, Alimuddin}} Category:British pathologists Category:Zambian Muslims Category:British people of Indian descent Category:Zambian infectious diseases specialists Category:Zambian people of Gujarati descent Category:Zambian emigrants to the United Kingdom Category:Living people Category:Gujarati people Category:1955 births Category:Fellows of the Royal Society of Biology Category:Knights Bachelor Category:British people of Gujarati descent Category:Naturalised citizens of the United Kingdom Category:British Muslims Category:20th-century British medical doctors Category:Zambian people of Indian descent Category:21st-century British medical doctors Category:NIHR Senior Investigators Category:Fellows of the African Academy of Sciences